We use Standard Operating Procedures (SOPs) – uniformly written instructions with thorough explanations – to document common tasks, procedures, and organizational practices. SOPs in clinical research define the group’s standard practices and daily research procedures to ensure that we carry out research tasks in compliance with institutional, state, and federal guidelines. We should create SOPs […]
Read More →Clinical trials in rare diseases are more challenging than clinical trials in more frequent diseases for many factors such as the trial design, the number of patient populations available for recruitment, regulatory support, etc. Applying a perfect strategy for clinical development in rare diseases may help overcome these challenges and accelerate the drug development process […]
Read More →Many people with rare diseases struggle to find the right diagnosis and right treatment for years. The lack of awareness about these conditions makes it much harder for them to get the right treatment. Rare Disease Day is all about raising awareness for rare diseases. And, this year, you can join these efforts too. The […]
Read More →In recent years, there is a huge leap in the pharma industry towards rare disease research and orphan drug developments due to the great support from regulatory authorities such as faster approval timelines, supportive regulatory frameworks, financial incentives, and many more. Currently, large pharmaceutical companies like Novartis, GSK, Roche, and Pfizer are extremely active in […]
Read More →Undoubtedly, the most critical roles in any clinical trial are the ones played by the investigators and site support staff. They’re the team that actually perform the activities leading up to or structuring an investigation of drug effects and safety. At Credevo.com, we strive to connect talented investigators and sites with new clinical trials requirements. […]
Read More →